The Thangam Cancer Centre IPN Clinic is India’s first dedicated Incidental Pulmonary Nodule (IPN) clinic designed to systematically detect and track lung nodules using Qure.ai’s FDA-cleared qXR solution

Qure.ai announced the launch of India’s first AI-led Incidental Pulmonary Nodule (IPN) Detection Clinic at Thangam Cancer Centre in Namakkal, Tamil Nadu. 

The initiative is part of Project BreatheEZ, a broader strategic collaboration between Qure.ai and Johnson & Johnson MedTech, India, designed to establish AI-powered IPN Clinics across leading hospitals in India. These clinics will act as integrated screening hubs, optimising early detection, triaging, and follow-up care for lung cancer patients. 

The Thangam Cancer Centre IPN Clinic is India’s first dedicated Incidental Pulmonary Nodule (IPN) clinic designed to systematically detect and track lung nodules using Qure.ai’s FDA-cleared qXR solution as part of an integrated screening and care pathway. The structured, AI-powered incidental screening programme, established within a hospital setting will enable the detection of nodules as small as 6 mm from routine chest X-rays. This minimally invasive, cost-effective approach unlocks the possibility of diagnosing lung cancer at an early stage, giving patients significantly better chances of survival and improved outcomes.

Dr Saravana Rajamanickam, Director, Surgical Thoracic Oncology, Thangam Cancer Centre & Research Institute, said, "Our vision has always been to bring the best of global healthcare technology to the people. With the launch of this AI-powered clinic, we are not only enhancing our ability to detect lung cancer early but also redefining cancer care for millions in India. Combining the precision of AI with advanced surgical techniques like robotics gives us a comprehensive pathway from early detection to advanced treatment, all under one roof."

Qure.ai’s qXR technology works by automatically flagging pulmonary nodules, often early indicators of lung cancer, on routine chest X-rays. The AI system also assists radiologists by providing malignancy risk scores, tracking nodule progression over time, and ensuring seamless care coordination between radiology, pulmonology, and oncology teams. 

Prashant Warier, CEO and Co-Founder, Qure.ai, said, "At Qure.ai, we are committed to bridging critical healthcare gaps with AI. The partnership with Thangam Cancer Centre to turn routine chest X-rays into early warning tools is a powerful example of the potential of our AI solutions. We look forward to scaling this model across India’s healthcare ecosystem."

This hub-and-spoke model, piloted at Thangam Cancer Centre, is expected to serve as a blueprint for similar AI-powered clinics across India, supported by Johnson & Johnson MedTech, India.